Literature DB >> 21743829

ANCA: A Family of Fluorescent Probes that Bind and Stain Amyloid Plaques in Human Tissue.

Willy M Chang1, Marianna Dakanali, Christina C Capule, Christina J Sigurdson, Jerry Yang, Emmanuel A Theodorakis.   

Abstract

A new family of fluorescent markers containing an Amino Naphthalenyl-2-Cyano-Acrylate (ANCA) motif has been synthesized and evaluated for its capability to associate with aggregated β-amyloid (Aβ) peptides. These fluorescent probes contain a nitrogen donor group that is connected via a naphthalene unit to an electron acceptor motif containing Water Solubilizing Groups (WSG). Chemical modifications were introduced to explore their effect on the capability of the ANCA-based probes to fluorescently label aggregated Aβ peptides. All synthesized probes bind to aggregated Aβ fibrils with low micromolar affinity and fluorescently stain amyloid deposits in human brain tissue from patients with Alzheimer's disease. We found that structural modifications of the WSG site do not affect considerably the binding affinity. However, changes of the nitrogen donor group alter significantly the binding affinity of these probes. Also, increasing the hydrophilicity of the donor group leads to improved contrast between the Aβ deposits and the surrounding tissue in histological staining experiments.

Entities:  

Year:  2011        PMID: 21743829      PMCID: PMC3129977          DOI: 10.1021/cn200018v

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  36 in total

1.  Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity.

Authors:  Lila K Habib; Michelle T C Lee; Jerry Yang
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation.

Authors:  Warren R Zipfel; Rebecca M Williams; Richard Christie; Alexander Yu Nikitin; Bradley T Hyman; Watt W Webb
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

3.  Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates.

Authors:  Karin A Stephenson; Rajesh Chandra; Zhi-Ping Zhuang; Catherine Hou; Shunichi Oya; Mei-Ping Kung; Hank F Kung
Journal:  Bioconjug Chem       Date:  2007 Jan-Feb       Impact factor: 4.774

Review 4.  Amyloid imaging in Alzheimer's disease.

Authors:  Agneta Nordberg
Journal:  Curr Opin Neurol       Date:  2007-08       Impact factor: 5.710

Review 5.  Translating cell biology into therapeutic advances in Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

Review 6.  Imaging-based measures of disease progression in clinical trials of disease-modifying drugs for Alzheimer disease.

Authors:  Brandy Matthews; Eric R Siemers; P David Mozley
Journal:  Am J Geriatr Psychiatry       Date:  2003 Mar-Apr       Impact factor: 4.105

7.  AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.

Authors:  Allan E Johnson; Fredrik Jeppsson; Johan Sandell; David Wensbo; Jan A M Neelissen; Anders Juréus; Peter Ström; Henrietta Norman; Lars Farde; Samuel P S Svensson
Journal:  J Neurochem       Date:  2009-01-24       Impact factor: 5.372

8.  Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.

Authors:  Joseph F Poduslo; Geoffry L Curran; Jane A Peterson; Daniel J McCormick; Abdul H Fauq; Murad A Khan; Thomas M Wengenack
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

9.  Evolution of a fourth generation catalyst for the amination and thioetherification of aryl halides.

Authors:  John F Hartwig
Journal:  Acc Chem Res       Date:  2008-11-18       Impact factor: 22.384

10.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

View more
  20 in total

1.  Bivalent ligand containing curcumin and cholesterol as fluorescence probe for Aβ plaques in Alzheimer's disease.

Authors:  Kai Liu; Tai L Guo; Jeremy Chojnacki; Hyoung-Gon Lee; Xinglong Wang; Sandra L Siedlak; Wei Rao; Xiongwei Zhu; Shijun Zhang
Journal:  ACS Chem Neurosci       Date:  2011-12-11       Impact factor: 4.418

2.  Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.

Authors:  Xueli Zhang; Yanli Tian; Can Zhang; Xiaoyu Tian; Alana W Ross; Robert D Moir; Hongbin Sun; Rudolph E Tanzi; Anna Moore; Chongzhao Ran
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

3.  Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease.

Authors:  Xueli Zhang; Yanli Tian; Zeng Li; Xiaoyu Tian; Hongbin Sun; Hong Liu; Anna Moore; Chongzhao Ran
Journal:  J Am Chem Soc       Date:  2013-10-25       Impact factor: 15.419

4.  Identification of Patients with Preeclampsia by Measuring Fluorescence of an Amyloid-Binding Aryl Cyano Amide in Human Urine Samples.

Authors:  Jamie P Do; Kevin J Cao; Sylvia Wei; Louise C Laurent; Mana M Parast; Jerry Yang
Journal:  Anal Chem       Date:  2018-12-03       Impact factor: 6.986

5.  Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection.

Authors:  Christina C Capule; Caitlin Brown; Joanna S Olsen; Stephen Dewhurst; Jerry Yang
Journal:  J Am Chem Soc       Date:  2012-01-03       Impact factor: 15.419

6.  Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.

Authors:  Yinghua Guan; Kevin J Cao; Adam Cantlon; Kristyna Elbel; Emmanuel A Theodorakis; Dominic M Walsh; Jerry Yang; Jagesh V Shah
Journal:  ACS Chem Neurosci       Date:  2015-07-31       Impact factor: 4.418

Review 7.  Advances in development of fluorescent probes for detecting amyloid-β aggregates.

Authors:  Ming-Ming Xu; Wen-Ming Ren; Xi-Can Tang; You-Hong Hu; Hai-Yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-03-21       Impact factor: 6.150

8.  Fluorescence detection of cationic amyloid fibrils in human semen.

Authors:  David Easterhoff; John T M DiMaio; Wathsala Liyanage; Chi-Wen Lo; Woori Bae; Todd M Doran; Alan Smrcka; Bradley L Nilsson; Stephen Dewhurst
Journal:  Bioorg Med Chem Lett       Date:  2013-07-08       Impact factor: 2.823

9.  BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques.

Authors:  Masahiro Ono; Hiroyuki Watanabe; Hiroyuki Kimura; Hideo Saji
Journal:  ACS Chem Neurosci       Date:  2012-02-17       Impact factor: 4.418

10.  Aminonaphthalene 2-cyanoacrylate (ANCA) probes fluorescently discriminate between amyloid-β and prion plaques in brain.

Authors:  Kevin Cao; Mona Farahi; Marianna Dakanali; Willy M Chang; Christina J Sigurdson; Emmanuel A Theodorakis; Jerry Yang
Journal:  J Am Chem Soc       Date:  2012-08-22       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.